Metraipolis › archive › dc_f2f2dc39bba2

Lung organoids for respiratory diseases: overcoming translational hurdles in drug discovery and safety assessment — Europe PMC PMID:42376297

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42376297
DOI: 10.3389/fbioe.2026.1859058
License (as archived): solo-consultazione
Archived: 2026-10-31T11:33:24.819Z
SHA-256 of the archived text: 7999d81e25c1c4d856fe035d1995a144bc5a3f6fd8f4a4c601b017e74f5413ba
Stable URL of this page: https://metraipolis.com/documento/dc_f2f2dc39bba2

How to cite

Lung organoids for respiratory diseases: overcoming translational hurdles in drug discovery and safety assessment — Europe PMC PMID:42376297 — Europe PMC (en), https://europepmc.org/article/MED/42376297 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f2f2dc39bba2 (Metraipolis archive dc_f2f2dc39bba2, sha256 7999d81e25c1c4d856fe035d1995a144bc5a3f6fd8f4a4c601b017e74f5413ba)

BibTeX

@misc{dcf2f2dc39bba2,
  title = {Lung organoids for respiratory diseases: overcoming translational hurdles in drug discovery and safety assessment — Europe PMC PMID:42376297},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42376297},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f2f2dc39bba2; sha256 7999d81e25c1c4d856fe035d1995a144bc5a3f6fd8f4a4c601b017e74f5413ba},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42376297. Agents can read the archived copy with the MCP tool read_document.